Author:
Mercuro G.,Rivano C. A.,Ruscazio M.,Lai L.,Manca R.,Rossetti Z. L.,Cherchi A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine,Pharmacology (medical)
Reference31 articles.
1. Barcroft H, Konzen H, Swan HJC. Observations on the actions of the hydrogenated alkaloids of the ergotoxine group on the circulation in man. Journal of Physiology 112: 273–291, 1951
2. Barrett RJ, Lokhandwala MF. Presynaptic dopamine receptor stimulation in the cardiovascular action of lergotrile. Journal of Pharmacology and Experimental Therapeutics 217: 660–665, 1981
3. Barrett RJ, Lokhandwala MF. Dopaminergic inhibition of cardiac sympathetic nerve function by pergolide. European Journal of Pharmacology 77: 79–83, 1982
4. Carey RM, Van Loon GR, Baines AD. Suppression of basal and stimulated noradrenergic activities by the dopamine agonist bromocriptine in man. Journal of Clinical Endocrinology and Metabolism 56: 595–602, 1983
5. Cavero I, Massingham R, Lefevre-Borg F. Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part I: subclassification and functional description. Life Sciences 31: 939–948, 1982